Revenue
2011
2012
2013
2017
2018
2019
2020
2021
2022
2023
2024
2025
Selectis Health, Inc. (GBCS)
Price$5.71Cached quote
Net income
2011
2012
2013
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2011
2012
2013
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2011
2012
2011
2013
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 · Dec 31 | 2013 · Jun 30 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.4M | $39.5M | $36.8M | $40.6M | $29.3M | $20.9M | $6.9M | $3.6M | $3.1M | — | — | — | — | $3.1M | $3.1M | $5.5M |
| Operating expenses | $43.0M | $42.2M | $45.7M | $40.9M | $30.0M | $17.6M | $5.6M | $3.3M | $2.7M | $2.9M | $4.8M | $2.5M | $766,519 | $3.1M | $3.2M | $6.8M |
| Operating income | −$1.6M | −$2.7M | −$9.0M | −$286,572 | −$728,992 | $3.4M | $1.3M | $339,972 | $464,513 | −$57,677 | −$1.3M | −$652,381 | −$323,186 | −$11,424 | −$81,746 | −$1.3M |
| Operating margin | −3.78% | −6.91% | −24.36% | −0.71% | −2.49% | 16.13% | 18.77% | 9.38% | 14.84% | — | — | — | — | −0.36% | −2.63% | −23.03% |
| EBITDA | −$90,254 | −$1.2M | −$7.3M | $1.5M | $1.0M | $5.0M | $2.7M | $1.6M | $1.7M | $1.4M | −$229,161 | −$28,070 | −$169,339 | $706,709 | $509,821 | −$837,997 |
| EBITDA margin | −0.22% | −2.94% | −19.83% | 3.71% | 3.43% | 23.68% | 38.28% | 44.11% | 54.45% | — | — | — | — | 22.52% | 16.38% | −15.19% |
| Net income | −$1.0M | −$2.4M | −$4.0M | −$2.4M | −$2.3M | $3.0M | −$861,614 | −$2.0M | −$3.0M | −$1.2M | −$3.3M | $1.4M | −$644,085 | −$1.8M | −$845,271 | −$1.4M |
| Net profit margin | −2.45% | −6.14% | −10.80% | −5.90% | −7.69% | 14.12% | −12.43% | −54.98% | −95.74% | — | — | — | — | −57.59% | −27.15% | −25.01% |
| Basic EPSper basic share | -$0.34 | -$0.80 | -$1.31 | -$0.79 | -$0.82 | $1.07 | -$0.30 | -$0.80 | -$1.20 | -$0.50 | -$1.50 | $0.70 | — | -$2.60 | -$1.30 | -$2.20 |
| Diluted EPSper diluted share | -$0.34 | -$0.80 | -$1.31 | -$0.79 | -$0.82 | $0.95 | -$0.30 | -$0.80 | -$1.20 | -$0.50 | -$1.50 | $0.60 | — | -$2.60 | -$1.30 | -$2.20 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Baller Lance | 294.37K |
Lund Kent Jeffrey | 19.25K |
Eckhart Krystal Diane | 1K |
Desmond Adam | — |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 31, 2025Form 5/A · 10b5-1 | Desmond AdamCEO | BuyCommon Stock | 1.3K | $2.25 | $2.9K | 53.1K |
| Dec 31, 2025Form 5 | Desmond AdamCEO | BuyCommon Stock | 1.3K | $2.25 | $2.9K | 53.1K |
| Dec 19, 2025Form 5/A · 10b5-1 | Desmond AdamCEO | BuyCommon Stock | 1.3K | $2.20 | $3.0K | 51.8K |
| Dec 19, 2025Form 5 | Desmond AdamCEO | BuyCommon Stock | 1.3K | $2.20 | $3.0K | 51.8K |
| Dec 18, 2025Form 4 | Baller LanceDirector,TenPercentOwner | BuyCommon Stock · indirect | 6.2K | $2.20 | $13.6K | 52.8K |